Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status

Bibliographic Details
Main Author: da Silva A.D.
Publication Date: 2024
Other Authors: Fracasso M., Bottari N.B., Palma T.V., Engelmann A.M., Castro M.F.V., Assmann C.E., Mostardeiro V., Reichert K.P., Nauderer J., da Veiga M.L., da Rocha M.I.U.M., Milleti L.C.*, das Neves G.B.*, Gundel S., Ourique A.F., Monteiro S.G., Morsch V.M., Chitolina M.R., Da Silva A.S.*
Format: Article
Language: eng
Source: Repositório Institucional da Udesc
dARK ID: ark:/33523/0013000005bjh
Download full: https://repositorio.udesc.br/handle/UDESC/1514
Summary: © 2024 by the authors.Background/Objectives: The Trypanosoma cruzi infection promotes an intense inflammatory process that affects several tissues. The cholinergic system may exert a regulatory immune response and control the inflammatory process. This study aimed to evaluate the comparative effect of free and nanoencapsulated benznidazole in acute T. cruzi infection to assess hematological, biochemical, and oxidative status triggered by the cholinergic system. Methods: For this, fifty female Swiss mice were distributed in eight groups, i.e., uninfected and infected animals under four treatment protocols: untreated (control—CT); vehicle treatment (Eudragit L 100—EL-100); benznidazole treatment (BNZ); and nanoencapsulated benznidazole treatment (NBNZ). After eight treatment days, the animals were euthanized for sample collection. Results: The peak of parasitemia was at day 7 p.i., and the BNZ and NBNZ controlled and reduced the parasite rate but showed no efficacy in terms of total elimination of parasites analyzed by RT-PCR in both infected groups. The infection promotes significant anemia, leukopenia, and thrombocytopenia, which the BNZ improves. There was an increase in AChE activity during infection, leading to a pro-inflammatory response and an increase in M1 and M2 mACh receptors in the BNZ group, showing that the treatment interacted with the cholinergic pathway. In addition, a pro-oxidative response was characterized in the infection and mainly in the infected BNZ and NBNZ groups. The histopathological analysis showed significative splenomegaly and inflammatory infiltrate in the heart, liver, and spleen. Conclusions: The administration of the BNZ or NBNZ reverses hematological, hepatic, and renal alterations through cholinergic signaling and stimulates a pro-inflammatory response during acute T. cruzi infection.
id UDESC-2_f75dd203421859d0c009a09bb34d33ab
oai_identifier_str oai:repositorio.udesc.br:UDESC/1514
network_acronym_str UDESC-2
network_name_str Repositório Institucional da Udesc
repository_id_str 6391
spelling Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status© 2024 by the authors.Background/Objectives: The Trypanosoma cruzi infection promotes an intense inflammatory process that affects several tissues. The cholinergic system may exert a regulatory immune response and control the inflammatory process. This study aimed to evaluate the comparative effect of free and nanoencapsulated benznidazole in acute T. cruzi infection to assess hematological, biochemical, and oxidative status triggered by the cholinergic system. Methods: For this, fifty female Swiss mice were distributed in eight groups, i.e., uninfected and infected animals under four treatment protocols: untreated (control—CT); vehicle treatment (Eudragit L 100—EL-100); benznidazole treatment (BNZ); and nanoencapsulated benznidazole treatment (NBNZ). After eight treatment days, the animals were euthanized for sample collection. Results: The peak of parasitemia was at day 7 p.i., and the BNZ and NBNZ controlled and reduced the parasite rate but showed no efficacy in terms of total elimination of parasites analyzed by RT-PCR in both infected groups. The infection promotes significant anemia, leukopenia, and thrombocytopenia, which the BNZ improves. There was an increase in AChE activity during infection, leading to a pro-inflammatory response and an increase in M1 and M2 mACh receptors in the BNZ group, showing that the treatment interacted with the cholinergic pathway. In addition, a pro-oxidative response was characterized in the infection and mainly in the infected BNZ and NBNZ groups. The histopathological analysis showed significative splenomegaly and inflammatory infiltrate in the heart, liver, and spleen. Conclusions: The administration of the BNZ or NBNZ reverses hematological, hepatic, and renal alterations through cholinergic signaling and stimulates a pro-inflammatory response during acute T. cruzi infection.2024-12-05T13:15:24Z2024info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1424-824710.3390/ph17101397https://repositorio.udesc.br/handle/UDESC/1514ark:/33523/0013000005bjhPharmaceuticals1710da Silva A.D.Fracasso M.Bottari N.B.Palma T.V.Engelmann A.M.Castro M.F.V.Assmann C.E.Mostardeiro V.Reichert K.P.Nauderer J.da Veiga M.L.da Rocha M.I.U.M.Milleti L.C.*das Neves G.B.*Gundel S.Ourique A.F.Monteiro S.G.Morsch V.M.Chitolina M.R.Da Silva A.S.*engreponame:Repositório Institucional da Udescinstname:Universidade do Estado de Santa Catarina (UDESC)instacron:UDESCinfo:eu-repo/semantics/openAccess2024-12-07T20:36:01Zoai:repositorio.udesc.br:UDESC/1514Biblioteca Digital de Teses e Dissertaçõeshttps://pergamumweb.udesc.br/biblioteca/index.phpPRIhttps://repositorio-api.udesc.br/server/oai/requestri@udesc.bropendoar:63912024-12-07T20:36:01Repositório Institucional da Udesc - Universidade do Estado de Santa Catarina (UDESC)false
dc.title.none.fl_str_mv Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status
title Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status
spellingShingle Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status
da Silva A.D.
title_short Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status
title_full Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status
title_fullStr Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status
title_full_unstemmed Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status
title_sort Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status
author da Silva A.D.
author_facet da Silva A.D.
Fracasso M.
Bottari N.B.
Palma T.V.
Engelmann A.M.
Castro M.F.V.
Assmann C.E.
Mostardeiro V.
Reichert K.P.
Nauderer J.
da Veiga M.L.
da Rocha M.I.U.M.
Milleti L.C.*
das Neves G.B.*
Gundel S.
Ourique A.F.
Monteiro S.G.
Morsch V.M.
Chitolina M.R.
Da Silva A.S.*
author_role author
author2 Fracasso M.
Bottari N.B.
Palma T.V.
Engelmann A.M.
Castro M.F.V.
Assmann C.E.
Mostardeiro V.
Reichert K.P.
Nauderer J.
da Veiga M.L.
da Rocha M.I.U.M.
Milleti L.C.*
das Neves G.B.*
Gundel S.
Ourique A.F.
Monteiro S.G.
Morsch V.M.
Chitolina M.R.
Da Silva A.S.*
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv da Silva A.D.
Fracasso M.
Bottari N.B.
Palma T.V.
Engelmann A.M.
Castro M.F.V.
Assmann C.E.
Mostardeiro V.
Reichert K.P.
Nauderer J.
da Veiga M.L.
da Rocha M.I.U.M.
Milleti L.C.*
das Neves G.B.*
Gundel S.
Ourique A.F.
Monteiro S.G.
Morsch V.M.
Chitolina M.R.
Da Silva A.S.*
description © 2024 by the authors.Background/Objectives: The Trypanosoma cruzi infection promotes an intense inflammatory process that affects several tissues. The cholinergic system may exert a regulatory immune response and control the inflammatory process. This study aimed to evaluate the comparative effect of free and nanoencapsulated benznidazole in acute T. cruzi infection to assess hematological, biochemical, and oxidative status triggered by the cholinergic system. Methods: For this, fifty female Swiss mice were distributed in eight groups, i.e., uninfected and infected animals under four treatment protocols: untreated (control—CT); vehicle treatment (Eudragit L 100—EL-100); benznidazole treatment (BNZ); and nanoencapsulated benznidazole treatment (NBNZ). After eight treatment days, the animals were euthanized for sample collection. Results: The peak of parasitemia was at day 7 p.i., and the BNZ and NBNZ controlled and reduced the parasite rate but showed no efficacy in terms of total elimination of parasites analyzed by RT-PCR in both infected groups. The infection promotes significant anemia, leukopenia, and thrombocytopenia, which the BNZ improves. There was an increase in AChE activity during infection, leading to a pro-inflammatory response and an increase in M1 and M2 mACh receptors in the BNZ group, showing that the treatment interacted with the cholinergic pathway. In addition, a pro-oxidative response was characterized in the infection and mainly in the infected BNZ and NBNZ groups. The histopathological analysis showed significative splenomegaly and inflammatory infiltrate in the heart, liver, and spleen. Conclusions: The administration of the BNZ or NBNZ reverses hematological, hepatic, and renal alterations through cholinergic signaling and stimulates a pro-inflammatory response during acute T. cruzi infection.
publishDate 2024
dc.date.none.fl_str_mv 2024-12-05T13:15:24Z
2024
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv 1424-8247
10.3390/ph17101397
https://repositorio.udesc.br/handle/UDESC/1514
dc.identifier.dark.fl_str_mv ark:/33523/0013000005bjh
identifier_str_mv 1424-8247
10.3390/ph17101397
ark:/33523/0013000005bjh
url https://repositorio.udesc.br/handle/UDESC/1514
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Pharmaceuticals
17
10
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da Udesc
instname:Universidade do Estado de Santa Catarina (UDESC)
instacron:UDESC
instname_str Universidade do Estado de Santa Catarina (UDESC)
instacron_str UDESC
institution UDESC
reponame_str Repositório Institucional da Udesc
collection Repositório Institucional da Udesc
repository.name.fl_str_mv Repositório Institucional da Udesc - Universidade do Estado de Santa Catarina (UDESC)
repository.mail.fl_str_mv ri@udesc.br
_version_ 1842258089252749312